StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $406.23MP/E –Yield –

Vireo Growth operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Vireo Growth's operating cash flow for the twelve months ending Jun 30, 2026 was $26.21M. For fiscal 2025 it was $3.71M. The highest annual figure on record is $3.71M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.71M–
FY2024Dec 31, 2024-$10.23M–
FY2023Dec 31, 2023-$965.91K–
FY2022Dec 31, 2022-$18.07M–
FY2021Dec 31, 2021-$30.52M–
FY2020Dec 31, 2020-$10.93M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.40M–
Q1 FY2026Mar 31, 2026$11.90M–
Q4 FY2025Dec 31, 2025$18.66M–
Q3 FY2025Sep 30, 2025-$6.74M–
Q2 FY2025Jun 30, 2025-$4.80M–
Q1 FY2025Mar 31, 2025-$3.40M–
Q4 FY2024Dec 31, 2024-$6.44M–
Q3 FY2024Sep 30, 2024-$2.59M-256.6%
Q2 FY2024Jun 30, 2024-$9.54K-100.6%
Q1 FY2024Mar 31, 2024-$1.19M–
Q4 FY2023Dec 31, 2023-$459.54K–
Q3 FY2023Sep 30, 2023$1.66M–
Q2 FY2023Jun 30, 2023$1.63M–
Q1 FY2023Mar 31, 2023-$3.79M–
Q4 FY2022Dec 31, 2022-$6.12M–
Q3 FY2022Sep 30, 2022-$2.11M–
Q2 FY2022Jun 30, 2022-$3.09M–
Q1 FY2022Mar 31, 2022-$6.76M–
Q4 FY2021Dec 31, 2021-$7.80M-12398.1%
Q3 FY2021Sep 30, 2021-$5.23M–
Q2 FY2021Jun 30, 2021-$12.52M–
Q1 FY2021Mar 31, 2021-$4.97M–
Q4 FY2020Dec 31, 2020$63.39K–
Q3 FY2020Sep 30, 2020-$3.51M–
Q2 FY2020Jun 30, 2020-$4.76M–
Q1 FY2020Mar 31, 2020-$2.73M–

More Vireo Growth figures

See a number that looks wrong?